JPRN-UMIN000024013已完成未知
A clinical study for evaluating the efficacy of "Zendamakin-no-chikara" containing Lactcoccus lactis subsp. Cremoris FC on fanction of intestinal bacterial flora regulation. -Randomised double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of "Zendamakin-no-chikara" containing Lactcoccus lactis subsp. Cremoris FC on fanction of intestinal bacterial flora regulation. -Randomised double-blind placebo-controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
The continuous ingestion of L. lactis subsp. cremoris FC caused changes in intestinal microflora, improving defecation status and fecal characteristics in healthy subjects prone to constipation.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Individuals taking antiflatulents and/or laxatives(including purgative drugs) in common use (2)Individuals taking health foods in common use, including food for specified health use, which influence intestinal regulation at the point of screening examination (3)Individuals taking antibiotics and/or drugs which influence laxatives(including purgative drugs) in common use at the point of screening examination (4)Individuals daily consuming alcohol as equivalent amount of sake more than 360ml (5)Individuals who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use, which influence intestinal regulation during the study period (6)Individuals presenting known food allergy (7)Individuals who are suffered from a disease which needs treatment urgently or individuals with severe complications (8)Individuals with a digestive organ disease or surgical history who has an influence on digestive absorption and defecation (9)Individuals infected with a disease to urgently need treatment, or having serious complications (10)Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (11)Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (12)Individuals who are judged as unsuitable for the study by the investigator for the other reasons
研究者
相似试验
已完成
不适用
Effect of 12-week Probiotic Consumption Immobilized on Oat Flakes on Blood and Urine Biomarkers and Human MicrobiomeHealthyNCT06293859University of the Aegean54
已完成
不适用
Elucidating the Influence of Lactulose Intake on the Gut Microbiota CompositionChanges in Gut Microbiota Composition After Lactulose ExposureNCT02397512University of Zurich32
已完成
不适用
Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.Anxious Healthy SubjectsNCT04780763Danone Research168
已完成
不适用
Intestinal Microbiota: Immunity, Recovery and Metabolic HealthHealthyNCT06355089University of Turku160
已完成
不适用
A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of MetforminHuman MicrobiomeNCT03809260Seoul National University Hospital20